Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testosterone | 37 | 2024 | 2472 | 2.560 |
Why?
|
Hypogonadism | 9 | 2024 | 798 | 2.040 |
Why?
|
Androgens | 11 | 2021 | 1283 | 1.250 |
Why?
|
Nicotinamide Mononucleotide | 2 | 2023 | 17 | 1.070 |
Why?
|
Sarcopenia | 7 | 2021 | 370 | 0.850 |
Why?
|
NAD | 3 | 2023 | 611 | 0.830 |
Why?
|
Hormone Replacement Therapy | 9 | 2024 | 751 | 0.810 |
Why?
|
Apolipoproteins B | 5 | 2024 | 385 | 0.810 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2022 | 550 | 0.730 |
Why?
|
Muscle Strength | 7 | 2020 | 624 | 0.720 |
Why?
|
Cholesterol, HDL | 8 | 2024 | 1812 | 0.710 |
Why?
|
Cardiovascular Diseases | 14 | 2024 | 15513 | 0.700 |
Why?
|
Erectile Dysfunction | 1 | 2024 | 444 | 0.700 |
Why?
|
Hand Strength | 5 | 2020 | 456 | 0.600 |
Why?
|
Receptors, Androgen | 2 | 2021 | 1077 | 0.570 |
Why?
|
Mobility Limitation | 6 | 2021 | 408 | 0.540 |
Why?
|
Body Composition | 9 | 2020 | 2427 | 0.530 |
Why?
|
Models, Theoretical | 2 | 2018 | 3568 | 0.470 |
Why?
|
Area Under Curve | 2 | 2018 | 1636 | 0.460 |
Why?
|
Anemia | 1 | 2023 | 1504 | 0.450 |
Why?
|
Malnutrition | 1 | 2020 | 622 | 0.430 |
Why?
|
Prostatectomy | 1 | 2021 | 1825 | 0.420 |
Why?
|
Overweight | 2 | 2023 | 2418 | 0.410 |
Why?
|
Insulin Resistance | 3 | 2023 | 3951 | 0.400 |
Why?
|
Risk Assessment | 11 | 2024 | 24013 | 0.360 |
Why?
|
Renal Artery Obstruction | 3 | 2016 | 218 | 0.360 |
Why?
|
Cholesterol, LDL | 4 | 2024 | 2380 | 0.360 |
Why?
|
Coronary Disease | 2 | 2023 | 5921 | 0.360 |
Why?
|
Aged | 53 | 2024 | 169266 | 0.350 |
Why?
|
Double-Blind Method | 19 | 2024 | 12341 | 0.330 |
Why?
|
Dietary Proteins | 3 | 2021 | 951 | 0.330 |
Why?
|
Consensus | 5 | 2020 | 3133 | 0.310 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11103 | 0.310 |
Why?
|
Myostatin | 2 | 2022 | 129 | 0.300 |
Why?
|
Middle Aged | 54 | 2024 | 220835 | 0.300 |
Why?
|
Independent Living | 5 | 2024 | 579 | 0.290 |
Why?
|
Muscle Weakness | 2 | 2020 | 412 | 0.280 |
Why?
|
Triglycerides | 3 | 2024 | 2457 | 0.280 |
Why?
|
Male | 73 | 2024 | 360675 | 0.270 |
Why?
|
Exercise Therapy | 3 | 2024 | 922 | 0.260 |
Why?
|
Heart | 1 | 2019 | 4431 | 0.250 |
Why?
|
Cholesterol | 3 | 2023 | 2902 | 0.250 |
Why?
|
Patient Readmission | 1 | 2020 | 3268 | 0.250 |
Why?
|
Spinal Cord Injuries | 2 | 2024 | 924 | 0.250 |
Why?
|
Albuminuria | 3 | 2018 | 656 | 0.250 |
Why?
|
Humans | 83 | 2024 | 761098 | 0.230 |
Why?
|
Cholesterol, VLDL | 1 | 2024 | 70 | 0.230 |
Why?
|
Muscle, Skeletal | 6 | 2022 | 4947 | 0.230 |
Why?
|
Apolipoprotein B-100 | 1 | 2024 | 157 | 0.220 |
Why?
|
Activities of Daily Living | 4 | 2021 | 2420 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 12145 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 106 | 0.210 |
Why?
|
Exercise | 1 | 2019 | 5872 | 0.210 |
Why?
|
Atherosclerosis | 5 | 2020 | 3405 | 0.210 |
Why?
|
Absorptiometry, Photon | 7 | 2024 | 1738 | 0.200 |
Why?
|
Dihydrotestosterone | 1 | 2022 | 195 | 0.200 |
Why?
|
Aging | 6 | 2018 | 8701 | 0.190 |
Why?
|
Body Mass Index | 8 | 2023 | 12951 | 0.180 |
Why?
|
Intra-Abdominal Fat | 2 | 2021 | 612 | 0.180 |
Why?
|
Tunica Media | 2 | 2011 | 110 | 0.180 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1866 | 0.180 |
Why?
|
Accidental Falls | 3 | 2024 | 1067 | 0.180 |
Why?
|
Carotid Artery, Common | 2 | 2011 | 175 | 0.170 |
Why?
|
Cohort Studies | 13 | 2022 | 41486 | 0.170 |
Why?
|
Hypertriglyceridemia | 1 | 2023 | 293 | 0.170 |
Why?
|
Stents | 3 | 2016 | 3177 | 0.170 |
Why?
|
Blood Glucose | 5 | 2022 | 6390 | 0.170 |
Why?
|
Lipoproteins | 2 | 2022 | 878 | 0.170 |
Why?
|
Androgen Antagonists | 2 | 2018 | 1408 | 0.170 |
Why?
|
HIV Infections | 3 | 2022 | 17349 | 0.160 |
Why?
|
Tandem Mass Spectrometry | 2 | 2022 | 1186 | 0.160 |
Why?
|
Tunica Intima | 2 | 2011 | 458 | 0.160 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 778 | 0.160 |
Why?
|
Chromatography, Liquid | 4 | 2022 | 982 | 0.150 |
Why?
|
Particle Size | 1 | 2023 | 1649 | 0.150 |
Why?
|
Prediabetic State | 1 | 2024 | 545 | 0.150 |
Why?
|
Prostate-Specific Antigen | 3 | 2023 | 2465 | 0.150 |
Why?
|
Eunuchism | 1 | 2017 | 19 | 0.150 |
Why?
|
Agrin | 1 | 2017 | 75 | 0.140 |
Why?
|
Hemoglobins | 1 | 2023 | 1525 | 0.140 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 131 | 0.140 |
Why?
|
Dyslipidemias | 2 | 2018 | 870 | 0.140 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2017 | 74 | 0.140 |
Why?
|
Models, Cardiovascular | 2 | 2020 | 983 | 0.140 |
Why?
|
Hysterectomy | 2 | 2019 | 856 | 0.140 |
Why?
|
Female | 43 | 2024 | 392458 | 0.140 |
Why?
|
Leuprolide | 1 | 2018 | 312 | 0.140 |
Why?
|
Aorta, Abdominal | 2 | 2017 | 625 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 295 | 0.140 |
Why?
|
Risk Factors | 15 | 2024 | 74219 | 0.130 |
Why?
|
Body Weight | 3 | 2023 | 4618 | 0.130 |
Why?
|
Physical Fitness | 2 | 2020 | 742 | 0.130 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 123 | 0.130 |
Why?
|
Metabolome | 1 | 2023 | 989 | 0.130 |
Why?
|
Finasteride | 1 | 2016 | 86 | 0.130 |
Why?
|
Mass Spectrometry | 1 | 2023 | 2189 | 0.130 |
Why?
|
Administration, Cutaneous | 4 | 2020 | 713 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 828 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58946 | 0.120 |
Why?
|
Erythrocyte Deformability | 1 | 2015 | 55 | 0.120 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2016 | 112 | 0.120 |
Why?
|
Gels | 3 | 2023 | 420 | 0.120 |
Why?
|
Adult | 27 | 2024 | 221083 | 0.120 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 190 | 0.120 |
Why?
|
Blood Viscosity | 1 | 2015 | 124 | 0.120 |
Why?
|
Exercise Test | 2 | 2020 | 2165 | 0.120 |
Why?
|
Erythropoiesis | 1 | 2018 | 683 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2021 | 836 | 0.110 |
Why?
|
Erythropoietin | 1 | 2018 | 719 | 0.110 |
Why?
|
Life Support Care | 1 | 2015 | 225 | 0.110 |
Why?
|
Metabolism | 1 | 2015 | 193 | 0.110 |
Why?
|
Joints | 1 | 2015 | 322 | 0.110 |
Why?
|
Sexual Behavior | 1 | 2024 | 2189 | 0.110 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6504 | 0.110 |
Why?
|
Pulsatile Flow | 1 | 2014 | 320 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 536 | 0.110 |
Why?
|
Renal Dialysis | 1 | 2022 | 1796 | 0.110 |
Why?
|
Bone Resorption | 1 | 2017 | 723 | 0.110 |
Why?
|
Quality of Life | 5 | 2022 | 13362 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2024 | 5249 | 0.100 |
Why?
|
Prospective Studies | 10 | 2024 | 54419 | 0.100 |
Why?
|
Primary Prevention | 1 | 2020 | 1185 | 0.100 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 541 | 0.100 |
Why?
|
Age Factors | 6 | 2020 | 18385 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 842 | 0.100 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2013 | 241 | 0.100 |
Why?
|
Alopecia | 1 | 2016 | 412 | 0.100 |
Why?
|
Vasodilator Agents | 1 | 2016 | 989 | 0.100 |
Why?
|
Voice | 1 | 2015 | 268 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1579 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 2045 | 0.100 |
Why?
|
Simian immunodeficiency virus | 1 | 2017 | 810 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2018 | 972 | 0.100 |
Why?
|
Spleen | 1 | 2017 | 2290 | 0.090 |
Why?
|
Glucose | 2 | 2024 | 4341 | 0.090 |
Why?
|
Aortic Diseases | 1 | 2017 | 735 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2570 | 0.090 |
Why?
|
Reproduction | 1 | 2015 | 646 | 0.090 |
Why?
|
Blood Pressure | 4 | 2016 | 8478 | 0.090 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26068 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1030 | 0.090 |
Why?
|
Blood Platelets | 1 | 2020 | 2477 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2193 | 0.080 |
Why?
|
Calcinosis | 1 | 2018 | 1477 | 0.080 |
Why?
|
Neck | 1 | 2013 | 734 | 0.080 |
Why?
|
Microcomputers | 1 | 2008 | 140 | 0.080 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 462 | 0.080 |
Why?
|
Coronary Vessels | 2 | 2017 | 3111 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9648 | 0.080 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 445 | 0.070 |
Why?
|
Aortic Valve | 1 | 2018 | 1959 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3245 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2181 | 0.070 |
Why?
|
Health Status | 2 | 2018 | 4077 | 0.070 |
Why?
|
Heart Septum | 1 | 2008 | 301 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3763 | 0.070 |
Why?
|
ROC Curve | 2 | 2012 | 3582 | 0.070 |
Why?
|
Treatment Outcome | 11 | 2024 | 64670 | 0.070 |
Why?
|
Clostridium Infections | 1 | 2014 | 557 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4372 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2020 | 3410 | 0.070 |
Why?
|
Calcium | 2 | 2017 | 5720 | 0.070 |
Why?
|
Heart Rate | 1 | 2018 | 4196 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4574 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2014 | 1725 | 0.060 |
Why?
|
Sex Factors | 5 | 2020 | 10552 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2016 | 2254 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6482 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5103 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2019 | 2869 | 0.060 |
Why?
|
Obesity | 3 | 2023 | 12937 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8130 | 0.060 |
Why?
|
Luteinizing Hormone | 2 | 2018 | 820 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2630 | 0.060 |
Why?
|
Lipids | 2 | 2018 | 3330 | 0.060 |
Why?
|
Phenotype | 1 | 2022 | 16572 | 0.060 |
Why?
|
Incidence | 6 | 2024 | 21357 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 10213 | 0.060 |
Why?
|
Computer Simulation | 2 | 2014 | 6225 | 0.060 |
Why?
|
Mental Health | 1 | 2018 | 3251 | 0.050 |
Why?
|
Cytokines | 1 | 2018 | 7386 | 0.050 |
Why?
|
Adiposity | 2 | 2014 | 1879 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.050 |
Why?
|
Massachusetts | 5 | 2017 | 8836 | 0.050 |
Why?
|
Musculoskeletal Diseases | 1 | 2008 | 597 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3821 | 0.050 |
Why?
|
Hypertension | 5 | 2016 | 8537 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2691 | 0.050 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2016 | 360 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 1270 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1395 | 0.050 |
Why?
|
Prevalence | 5 | 2020 | 15717 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7034 | 0.050 |
Why?
|
Hip Fractures | 2 | 2020 | 989 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7513 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29672 | 0.050 |
Why?
|
Atrial Fibrillation | 3 | 2015 | 5115 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 3051 | 0.050 |
Why?
|
Growth Differentiation Factors | 1 | 2022 | 100 | 0.050 |
Why?
|
Organ Size | 2 | 2017 | 2253 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2009 | 1720 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10755 | 0.050 |
Why?
|
Time Factors | 6 | 2018 | 39953 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36418 | 0.050 |
Why?
|
Fatigue | 2 | 2018 | 1550 | 0.050 |
Why?
|
Radius | 1 | 2024 | 442 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12467 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 13254 | 0.040 |
Why?
|
Stroke | 3 | 2023 | 9720 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2024 | 702 | 0.040 |
Why?
|
Lung | 1 | 2018 | 9979 | 0.040 |
Why?
|
Insulin | 3 | 2018 | 6588 | 0.040 |
Why?
|
Echocardiography | 2 | 2010 | 5006 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2008 | 1312 | 0.040 |
Why?
|
Postural Balance | 1 | 2024 | 623 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2022 | 539 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2010 | 2130 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4766 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 6987 | 0.040 |
Why?
|
Pelvic Floor | 1 | 2019 | 138 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2019 | 124 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2018 | 157 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10758 | 0.040 |
Why?
|
Young Adult | 7 | 2022 | 59199 | 0.040 |
Why?
|
Reference Standards | 1 | 2022 | 1005 | 0.040 |
Why?
|
Disease Progression | 4 | 2018 | 13506 | 0.040 |
Why?
|
Tibia | 1 | 2024 | 1070 | 0.040 |
Why?
|
Estradiol | 2 | 2015 | 1936 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2010 | 3812 | 0.040 |
Why?
|
Bone Density | 2 | 2024 | 3548 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2125 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12058 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2018 | 375 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2010 | 3899 | 0.030 |
Why?
|
Life Style | 1 | 2008 | 3908 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2019 | 80673 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15308 | 0.030 |
Why?
|
Prolactin | 1 | 2018 | 625 | 0.030 |
Why?
|
Gait | 1 | 2021 | 810 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2023 | 1722 | 0.030 |
Why?
|
Utah | 1 | 2015 | 130 | 0.030 |
Why?
|
Ferritins | 1 | 2018 | 597 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2017 | 39121 | 0.030 |
Why?
|
Coronary Angiography | 2 | 2017 | 4506 | 0.030 |
Why?
|
Prostate | 1 | 2023 | 1772 | 0.030 |
Why?
|
Estrous Cycle | 1 | 2015 | 65 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 1178 | 0.030 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2015 | 110 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 531 | 0.030 |
Why?
|
Aortography | 1 | 2017 | 421 | 0.030 |
Why?
|
Viremia | 1 | 2018 | 707 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1577 | 0.030 |
Why?
|
North America | 1 | 2018 | 1281 | 0.030 |
Why?
|
Sound Spectrography | 1 | 2015 | 113 | 0.030 |
Why?
|
Reference Values | 1 | 2022 | 4922 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1229 | 0.030 |
Why?
|
Walking | 1 | 2021 | 1194 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1666 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1338 | 0.030 |
Why?
|
Hypertrophy | 1 | 2015 | 558 | 0.030 |
Why?
|
Aminoglycosides | 1 | 2014 | 160 | 0.030 |
Why?
|
Pelvis | 1 | 2018 | 734 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2015 | 3309 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2015 | 726 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14607 | 0.030 |
Why?
|
Systems Analysis | 1 | 2013 | 169 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2020 | 1834 | 0.030 |
Why?
|
Orchiectomy | 1 | 2015 | 463 | 0.030 |
Why?
|
Models, Statistical | 2 | 2020 | 5077 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 613 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1409 | 0.030 |
Why?
|
Manometry | 1 | 2014 | 453 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2015 | 583 | 0.020 |
Why?
|
Creatine | 1 | 2014 | 427 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3422 | 0.020 |
Why?
|
Recovery of Function | 1 | 2022 | 2981 | 0.020 |
Why?
|
Voice Disorders | 1 | 2015 | 284 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2024 | 3727 | 0.020 |
Why?
|
Tendons | 1 | 2015 | 558 | 0.020 |
Why?
|
HIV | 1 | 2018 | 1581 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2927 | 0.020 |
Why?
|
Ovary | 1 | 2015 | 957 | 0.020 |
Why?
|
Muscles | 1 | 2015 | 1567 | 0.020 |
Why?
|
Vancomycin | 1 | 2014 | 503 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1039 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4036 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2328 | 0.020 |
Why?
|
Affect | 1 | 2018 | 1486 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1520 | 0.020 |
Why?
|
Extremities | 1 | 2015 | 867 | 0.020 |
Why?
|
Femoral Artery | 1 | 2014 | 826 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11475 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2014 | 941 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3266 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2666 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1885 | 0.020 |
Why?
|
United States | 4 | 2020 | 72337 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 1039 | 0.020 |
Why?
|
Energy Intake | 1 | 2017 | 2133 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1504 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 974 | 0.020 |
Why?
|
Osteogenesis | 1 | 2015 | 1272 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2896 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2015 | 1208 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11856 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3689 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15845 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2014 | 1096 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4565 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20120 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6817 | 0.020 |
Why?
|
Menopause | 1 | 2015 | 1646 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22129 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2205 | 0.020 |
Why?
|
Bone Marrow | 1 | 2017 | 2911 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3450 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6781 | 0.020 |
Why?
|
Probability | 1 | 2011 | 2478 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2413 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2712 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8639 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2008 | 393 | 0.020 |
Why?
|
Lung Diseases | 1 | 2015 | 1909 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3367 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2016 | 2057 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2746 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3598 | 0.010 |
Why?
|
Hemodynamics | 1 | 2014 | 4164 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6385 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7567 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2478 | 0.010 |
Why?
|
Animals | 4 | 2017 | 168083 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7043 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10083 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2015 | 4028 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9614 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12727 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2359 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10514 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8456 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6178 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3808 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10203 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12743 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5869 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14393 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12670 | 0.010 |
Why?
|
Mice | 2 | 2015 | 81324 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5971 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15915 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5841 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10712 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 88271 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7405 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14676 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20600 | 0.010 |
Why?
|